Intravitreal Bevaxizumab injection for intraocular neovasculalization in children

Intravitreal Bevaxizumab injection for intraocular neovasculalization in children - Bevacizumab therapy for retinopathy of prematurity

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000007465

Enrollment

Registered

2012-04-01

Start date

2012-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

retinopathy of prematurity

Interventions

Intravitreal bevacizumab for treatment

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Outpatient of Tokushima University with with intraocular neovasculalization

Exclusion criteria

Exclusion criteria: subjects with systemic risk factors

Design outcomes

Primary

Measure	Time frame
visual acuity retinal angiography	—

Countries

Japan

Contacts

Public ContactKayo Shinomiya

Tokushima university hospital Department of Ophthalmology

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026